These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Musculoskeletal manifestations of lysosomal storage disorders. Aldenhoven M; Sakkers RJ; Boelens J; de Koning TJ; Wulffraat NM Ann Rheum Dis; 2009 Nov; 68(11):1659-65. PubMed ID: 19822711 [TBL] [Abstract][Full Text] [Related]
28. Electron microscopy of intestinal suction-biopsy specimens as an aid in the diagnosis of mucopolysaccharidoses and other lysosomal storage diseases. Van Gemund JJ; Daems WT; Vio PA; Giesberts MA Maandschr Kindergeneeskd; 1971 Oct; 39(7):211-7. PubMed ID: 4258610 [No Abstract] [Full Text] [Related]
29. [Mucopolysaccharidoses--current aspects of diagnosis and therapy]. Fang-Kircher S Wien Klin Wochenschr; 1995; 107(22):698-701. PubMed ID: 8533432 [TBL] [Abstract][Full Text] [Related]
30. [Therapeutic trials in mucopolysaccharidosis]. Di Ferrante N Minerva Pediatr; 1975 Mar; 27(8):462-70. PubMed ID: 123308 [No Abstract] [Full Text] [Related]
31. Syndrome of the defective lysosome--the genetic mucopolysaccharidoses. Rennert OM Ann Clin Lab Sci; 1975; 5(5):355-62. PubMed ID: 810065 [TBL] [Abstract][Full Text] [Related]
32. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses. Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095 [TBL] [Abstract][Full Text] [Related]
33. Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses: an evaluation. Gray G; Claridge P; Jenkinson L; Green A Ann Clin Biochem; 2007 Jul; 44(Pt 4):360-3. PubMed ID: 17594782 [TBL] [Abstract][Full Text] [Related]
34. Early presentation in the mucopolysaccharide disorders. Colville GA; Bax MA Child Care Health Dev; 1996 Jan; 22(1):31-6. PubMed ID: 8640962 [TBL] [Abstract][Full Text] [Related]
35. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. Hochuli M; Wüthrich K; Steinmann B NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120 [TBL] [Abstract][Full Text] [Related]
36. [Mucopolysaccharidosis: A review]. Michaud M; Belmatoug N; Catros F; Ancellin S; Touati G; Levade T; Gaches F Rev Med Interne; 2020 Mar; 41(3):180-188. PubMed ID: 31959364 [TBL] [Abstract][Full Text] [Related]
37. [Urinary excretion of mucopolysaccharides in pediatric and adolescent patients]. de la Cruz Amorós V; Cortés Castell E; Moya M An Esp Pediatr; 1999 Apr; 50(4):361-6. PubMed ID: 10356828 [TBL] [Abstract][Full Text] [Related]
38. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042 [TBL] [Abstract][Full Text] [Related]
39. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia. Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975 [TBL] [Abstract][Full Text] [Related]